We sought to determine if myocardial energetics could distinguish obesity cardiomyopathy as a distinct entity from dilated cardiomyopathy.
Sixteen normal weight participants with dilated cardiomyopathy (DCM NW), and 27 with DCM and obesity (DCM OB), were compared to 26 normal weight controls (CTL NW). All underwent cardiac magnetic resonance imaging and 31P spectroscopy to assess function and energetics. Nineteen DCM OB underwent repeat assessment after a dietary weight loss intervention. Adenosine triphosphate (ATP) delivery through creatine kinase (CK flux) was 55% lower in DCM NW than in CTL NW ( P = 0.004), correlating with left ventricular ejection fraction (LVEF, r = 0.4, P = 0.015). In contrast, despite similar LVEF (DCM OB 41 ± 7%, DCM NW 38 ± 6%, P = 0.14), CK flux was two-fold higher in DCM OB ( P < 0.001), due to higher rate through CK [median k f 0.21 (0.14) vs. 0.11 (0.12) s −1, P = 0.002]. During increased workload, the CTL NW heart increased CK flux by 97% ( P < 0.001). In contrast, CK flux was unchanged in DCM NW and fell in DCM OB (by >50%, P < 0.001). Intentional weight loss was associated with positive left ventricular remodelling, with reduced left ventricular end-diastolic volume (by 8%, P < 0.001) and a change in LVEF (40 ± 9% vs. 45 ± 10%, P = 0.002). This occurred alongside a fall in ATP delivery rate with weight loss (by 7%, P = 0.049).
In normal weight, DCM is associated with reduced resting ATP delivery. In obese DCM, ATP demand through CK is greater, suggesting reduced efficiency of energy utilization. Dietary weight loss is associated with significant improvement in myocardial contractility, and a fall in ATP delivery, suggesting improved metabolic efficiency. This highlights distinct energetic pathways in obesity cardiomyopathy, which are both different from dilated cardiomyopathy, and may be reversible with weight loss.